Elliptic Laboratories ASA
Elliptic Laboratories ASA develops and licenses ultrasonic sensing software for mobile devices and IoT applications, generating revenue through software licensing and royalty agreements.
Business. Elliptic Laboratories ASA (ELABS.OL) is a software company operating within the Technology sector, specifically focused on Software & IT Services. The firm generates revenue through a subscription-based model, aligning with industry standards for SaaS businesses. As no specific operating segments or geographic breakdowns are provided, the company is described at the industry level. Elliptic Laboratories is listed under the ticker ELABS.OL.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Peers
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Elliptic Laboratories ASA (ELABS.OL) is a software company operating within the Technology sector, specifically focused on Software & IT Services. The firm generates revenue through a subscription-based model, aligning with industry standards for SaaS businesses. As no specific operating segments or geographic breakdowns are provided, the company is described at the industry level. Elliptic Laboratories is listed under the ticker ELABS.OL.
Elliptic Laboratories maintains a strong liquidity position with NOK 99.9 million in cash and equivalents, representing 29% of total assets, and a current ratio of 6.79, well above the industry median. The company's price-to-book ratio of 1.31 suggests market valuation is modestly above tangible asset value, while the debt-to-equity ratio of 0.08 indicates minimal leverage.
Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of NOK 2.6 million and operating loss of NOK 8.3 million, resulting in negative ROE (-0.86%) and ROA (-0.76%). These results contrast sharply with the median ROE of 12-15% in the software industry.
Geographically, Elliptic's revenue is concentrated in a single product line (ultrasonic sensing software), with no disclosed geographic segmentation. This concentration exposes the company to demand volatility in its core technology market.
Growth prospects remain uncertain. The company's FY2024 revenue of NOK 22.2 million represents a 12% decline from FY2023, with no clear path to profitability. Analysts project a mean EPS of NOK 0.48 for FY2025, a 136% improvement from the FY2024 actual of NOK -1.32, but this remains speculative given the company's consistent losses.
Risk factors include operational losses, negative cash flow from operations (NOK -8.3 million), and a free cash flow deficit (NOK -4.9 million). No immediate dilution risks are identified, with basic and diluted shares outstanding aligned at 115.8 million.
Recent filings show no material events impacting operations or capital structure. The company's 2023 annual report highlights ongoing R&D investments in sensor fusion technologies, but no new product launches or customer acquisitions were disclosed in the latest quarterly reports.
- Strong liquidity position with NOK 99.9 million in cash and a current ratio of 6.79
- Negative profitability metrics (ROE -0.86%, ROA -0.76%) indicate operational challenges
- Revenue decline of 12% in FY2024 raises concerns about market adoption of core technology
- Analysts project a 136% EPS improvement for FY2025, but this remains speculative
- No immediate dilution risks identified, with basic and diluted shares aligned
Bull / Bear case
Generated · model-assistedRevenue grew 16.7% CAGR over four years, demonstrating strong top-line expansion despite recent volatility.
The company achieved profitability in FY2025 with positive net income of 8.96 million NOK.
Cash conversion is best-in-class at 3.18, significantly outperforming the software cohort median of 0.92.
Leverage remains low with a debt-to-equity ratio of 0.11, providing financial flexibility.
A single analyst recommendation is a buy, indicating positive sentiment from market coverage.
The company faces high credit risk, signaling potential difficulties in meeting financial obligations.
In focus — financials by report
Revenue kr 42.0M, −11,7% YoY; Operating income −152,8% YoY.
- ▍Revenue kr 42.0M, −11,7% YoY
- ▍Operating income −152,8% YoY
- ▍Net income −968,1% YoY
- ▍Free cash flow −1 083,4% YoY
- ▍Net margin -226.6%
Revenue kr 42.3M, +49,7% YoY; Operating income +239,6% YoY.
- ▍Revenue kr 42.3M, +49,7% YoY
- ▍Operating income +239,6% YoY
- ▍Net income +193,5% YoY
- ▍Free cash flow +140,8% YoY
- ▍Net margin 9.1%
Revenue kr 24.6M, −27,4% YoY; Operating income −176,5% YoY.
- ▍Revenue kr 24.6M, −27,4% YoY
- ▍Operating income −176,5% YoY
- ▍Net income −273,4% YoY
- ▍Free cash flow −672,9% YoY
- ▍Net margin -33.5%
Revenue kr 26.6M, +19,7% YoY; Operating income +16,3% YoY.
- ▍Revenue kr 26.6M, +19,7% YoY
- ▍Operating income +16,3% YoY
- ▍Net income −358,8% YoY
- ▍Free cash flow −187,1% YoY
- ▍Net margin -45.1%
Revenue kr 47.6M; Operating income kr 11.1M.
- ▍Revenue kr 47.6M
- ▍Operating income kr 11.1M
- ▍Net margin 23.0%
Revenue kr 28.2M; Operating income -kr 4.6M.
- ▍Revenue kr 28.2M
- ▍Operating income -kr 4.6M
- ▍Net margin -14.6%
Revenue kr 33.9M; Operating income kr 6.4M.
- ▍Revenue kr 33.9M
- ▍Operating income kr 6.4M
- ▍Net margin 14.0%
Revenue kr 22.2M; Operating income -kr 8.3M.
- ▍Revenue kr 22.2M
- ▍Operating income -kr 8.3M
- ▍Net margin -11.8%
Revenue kr 101.3M, −23,2% YoY; Operating income −1 064,8% YoY.
- ▍Revenue kr 101.3M, −23,2% YoY
- ▍Operating income −1 064,8% YoY
- ▍Net income −1 641,8% YoY
- ▍Free cash flow −12 426,3% YoY
- ▍Net margin -136.4%
Revenue kr 131.9M, +93,1% YoY; Operating income +109,4% YoY.
- ▍Revenue kr 131.9M, +93,1% YoY
- ▍Operating income +109,4% YoY
- ▍Net income +123,5% YoY
- ▍Free cash flow +97,6% YoY
- ▍Net margin 6.8%
Revenue kr 68.3M, +31,2% YoY; Operating income −18,4% YoY.
- ▍Revenue kr 68.3M, +31,2% YoY
- ▍Operating income −18,4% YoY
- ▍Net income −15,5% YoY
- ▍Free cash flow −5,5% YoY
- ▍Net margin -55.8%
Revenue kr 52.1M, −4,6% YoY; Operating income −278,2% YoY.
- ▍Revenue kr 52.1M, −4,6% YoY
- ▍Operating income −278,2% YoY
- ▍Net income −194,3% YoY
- ▍Free cash flow −119,4% YoY
- ▍Net margin -63.4%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,48 |
| Revenue | —no estimate | —no estimate | 214,0M NOK |
| Operating income | —no estimate | —no estimate | 59,0M NOK |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Elliptic Laboratories ASA Market data — financials · 2026-05-27
- Elliptic Laboratories ASA Market data — analyst estimates · 2026-05-27
Ownership & reference
Leadership
- Laila B. DanielsenPresident, Chief Executive Officer
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Return on assets (FY 2024-12-31): 2.2%Derived (calculated)
- Return on equity (FY 2024-12-31): 2.5%Derived (calculated)
- Net margin (FY 2024-12-31): 5.9%Derived (calculated)
- Current ratio (FY 2024-12-31): 7.40xDerived (calculated)
- Debt-to-equity (FY 2024-12-31): 0.11xDerived (calculated)
- Current assets (annual): NOK 187.96MBRREG filing
- Pre-tax income (annual): NOK 15.98MBRREG filing
- Operating income (annual): NOK 3.73MBRREG filing
- Current liabilities (annual): NOK 25.4MBRREG filing
- Total operating expenses (annual): NOK 129.62MBRREG filing
- Net income (annual): NOK 7.91MBRREG filing
- Finance expense (annual): NOK 4.62MBRREG filing
- Total assets (annual): NOK 353.52MBRREG filing
- Non current liabilities (annual): NOK 10.73MBRREG filing
- Revenue (annual): NOK 133.34MBRREG filing
- Total equity & liabilities (annual): NOK 353.52MBRREG filing
- Total liabilities (annual): NOK 36.13MBRREG filing
- Shareholders' equity (annual): NOK 317.39MBRREG filing
- Non current assets (annual): NOK 165.56MBRREG filing